Werfen to Acquire Immucor for $2B
Werfen said the acquisition will allow it to expand its portfolio of specialized diagnostics solutions for hospitals and clinical laboratories.
FDA Clears Immucor Blood Compatibility Test for Sickle Cell Trait
The test can now be used to screen for sickle cell trait, a condition in which an individual carries one of the two abnormal genes responsible for sickle cell disease.
Medicare Contractors Finalize Local Coverage Determinations for Immucor PreciseType
Immucor's PreciseType evaluates blood compatibility between donors and patients to help prevent mismatches that can cause potentially life-threatening reactions.
Immucor Acquires Sirona Genomics
The two companies have had a years-long collaboration to develop and commercialize their NGS-based high-resolution HLA typing system.
In Sentilus Acquisition, Immucor Sees 'Inherent Value' of Microarrays for In Vitro Diagnostics
NEW YORK (GenomeWeb) – Immucor last week announced its acquisition of Sentilus, an early stage company developing microarray-based applications for clinical use, including transfusion diagnostics.
Oct 2, 2014
Immucor Buying Femtoarrays Developer Sentilus
May 22, 2014
FDA Approves Immucor's Blood Compatibility MDx Test
Nov 13, 2012
May 10, 2011
IP Roundup: May 10, 2011
Apr 19, 2011
Apr 19, 2011
People in the News: Apr 19, 2011
Jul 20, 2010